Phase 2

Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia

Sponsor:

Christoph Hornik

Code:

NCT04447989

Conditions

Bronchopulmonary Dysplasia of Newborn

Eligibility Criteria

Sex: All

Age: 0 - 29

Healthy Volunteers: Not accepted

Interventions

Sildenafil

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information